Molecule to Market: Inside the outsourcing space

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, Managing Director at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Insights, trends and advice for CROs, CDMOs and pharma services firms from one of the most prominent life science consultan...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Aldridge, Chief Strategy Officer at Form Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: How a family ritual of solving puzzles played a role in developing an entrepreneurial spirit of problem solving Learn...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Harry Christiaens, CEO at Ardena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Harry, covering: How a regulatory change led a small consultancy down the path of becoming one of Europe’s most respected mid-sized CDMOs The easy-theory o...

In this special episode of Molecule to Market, we are marking our 100th episode! Join us as we look back, review our learnings and lay the land for episode 101… For those that have been here since the beginning, we are incredibly grateful for your constant support and feedback. To our new listeners, thank you for joining the journey, seeing us through to 30,000 downloads and beyond.  To our guests...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the last 12 months in the life science industry. He covers his 5 key trends from the year including: The biotech capital market slowdown and its impact on the outsourcing space Sustainability as the hot topic within the sector, from event...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with a look back to some of our early guests from the Molecule to Market archive. Your host, Raman Sehgal, recaps his discussions on the pharmaceutical and biotechnology supply chain with: Stefano Console, founder and Senior Advisor at Oriento discussing: founding his business in Swi...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sarah Stevens, SVP and Head of Early Development & Late Stage Commercial Operations at Quotient Sciences.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sarah, covering:   Carving an incredible transatlantic CDMO career in traditional...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with independent life sciences consultant Jim Miller. Your host, Raman Sehgal sits down with Jim covering: The three biggest macro factors impacting the CDMO space right now How CDMOs and CROs are starting to feel the pain of emerging biotech’s funding woes What we can learn from the...

As we celebrate the podcast hitting 30,000 downloads and approaching its 100th episode, Raman reflects on the most downloaded episodes with highlights from the top 5.   In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector, diving into the top 5 episodes of all time, featuring: JoyL Silva, Pfizer CentreOne discussing: her early career j...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses emerging trends and challenges for the life sciences sector live from CPHI Frankfurt 2022, with: Grainne Hughes, Vice President of Business Support Operations at Almac  Christine Fürst, Senior Director Key Account Manager Europe at Vetter P...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal , who discusses future industry trends live from AAPS Boston 2022, with: Casey Franklin , VP of Business Development at Alcami Umberto Romeo , R&D Manager at Corden Pharma Steven Dodd , Executive Director for sales strategy at Icon CRO Paul Dickinson , Fo...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Katz , Founder & CSO at Sparrow Pharmaceuticals, Inc. Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with David, covering: The contrast of developing new drugs and running clinical trials in a big pharma versus his journey as the foun...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with  Jason McKenna , Global President, and  Dean McAlister , Executive Vice President both from  Inizio Biotech . Your host,  Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with the dynamic duo, covering: A wealth of big pharma learnings for today’s emerg...

In this special episode of Molecule to Market, we go back inside the global drug development space with  Marcelo Bigal , President and CEO, of  Ventus Therapeutics , and Versant Venture Partner, who shares his journey from being a neurologist to taking a drug to market when he became part of Teva Pharmaceuticals and now is a CEO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnol...

In this special repurposed episode of Molecule to Market, we go back inside the global drug development space with previous guests  Magnus Gustafsson , Board Member at  Genovis ,  Jeff Dill , CEO at  Vynamic . , and  Peter Soelkner , Managing Director at  Vetter  to hear their thoughts on building a great organisational culture.  Your host,  Raman Sehgal , revisits discussions from past episodes,...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Evelyn Kelly, Chief Executive Officer at Orphan Drug Consulting . Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with Evelyn, covering: A deep dive into the world of orphan drugs, rare diseases and personalised medicines including the backg...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chuck Frey , VP Scientific Affairs at Coating Place . Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with Chuck, covering: The backstory to Wurster coating technology and how it changed the world of formulation development. Being the go-to...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Allan Shaw , Consulting CFO, Special Advisor & Board Member of several biotech companies. Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with Allan, covering: The sensitive cash position of biotech's as a ‘hangover’ after a decade of partyi...

In this special episode of Molecule to Market, we go back inside the global drug development space with previous guests  Go van Dam , CEO & Founder at  TRACER ,   Michelle Duggan , Inward Investment Manager,  Invest North East England ,  Peter Soelkner , Managing Director at  Vetter  and  Ross Burn , Chief Executive at  CatSci. Your host,  Raman Sehgal , revisits discussions around trends in the b...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Adrienne Leussa , Director of Ecosystem Partnerships at 54gene .Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with Adrienne, covering: How the reality of the health challenges living in Africa as a child drove Adrienne into the drug disco...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Enloe , President and CEO at Societal™ CDMO. Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with David, covering: Being at the birth of viral vectors and the-infant gene therapy field in the 90s... but choosing not to be there today. ...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ata Tuna Ciftlik CEO at Lunaphore .Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ata, covering: Bringing the next generation ‘satellite for tumours’ sequencing tools for immuno oncology and cancer research to drug discovery, and eventu...

In this special one-off episode of Molecule to Market, your host Raman Sehgal embarks on a solo cast to cover some of the major supply chain themes uncovered through Molecule to Market interviews. The insights were originally delivered live on stage at CPhI North America 2022. Whether you’re a CDMO, CPO, drug sponsor or equipment vendor - this is not to be missed. Your host, Raman, covers: 4 main...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses the pharmaceutical and biotechnology supply chain live from CPhI North America 2022, with: Robert Lee, President at Lubrizol Life Science Health - CDMO Division at The Lubrizol Corporation Lauren (Naughton) Hanna, Publisher at Contract Phar...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Wilson , President - BioPharmGuy. Your host, Raman Sehgal , discusses the pharmaceutical and biotechnology supply chain with Adam, covering: The humble start-up story and journey of the biopharmguy. The pivot that took the website from being a job sharing site to one of the...